Stockscreener 앱 받기
5.45
3.22%
0.17
Inovio Pharmaceuticals Inc (INO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
100.00%
-
|
0.1027 | 0.3884 | 0.226 | 0.1149 |
Operating Expenses
|
14.51%
31.48
|
27.50 | 35.94 | 37.27 | 44.07 |
| Interest Income/Expense |
37.01%
0.1778
|
0.2823 | 0.3135 | 0.3135 | 0.3135 |
| Operating Income/Loss |
14.93%
-31.48
|
-27.39 | -35.55 | -37.04 | -43.95 |
| Income/Loss From Continuing Operations Before Tax |
21.86%
-30.47
|
-25.00 | -33.93 | -35.53 | -40.65 |
| Income/Loss From Continuing Operations After Tax |
22.02%
-30.47
|
-24.97 | -33.93 | -35.53 | -40.65 |
|
Net Income/Loss
|
21.86%
-30.47
|
-25.00 | -33.93 | -35.53 | -40.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
109.64%
23.29
|
-241.67 | 268.62 | 264.35 | 258.44 |
| Diluted Average Shares |
109.64%
23.29
|
-241.67 | 268.62 | 264.35 | 258.44 |
| Basic Earnings Per Share |
76.90%
-1.31
|
-5.67 | -0.13 | -0.13 | -0.16 |
| Diluted Earnings Per Share |
76.90%
-1.31
|
-5.67 | -0.13 | -0.13 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.08%
1.43%
자본화:
|
볼륨(24시간):